Cite
HARVARD Citation
Smolen, J. et al. (2014). FRI0326 Efficacy and Safety of Tabalumab, an Anti-B Cell Activating Factor Monoclonal Antibody, in Patients with Rheumatoid Arthritis Who HAD an Inadequate Response to Methotrexate Therapy: Results from A Phase 3 Multicenter, Randomized, Double-Blind Study. Annals of the rheumatic diseases. p. 504. [Online].